A spokeswoman at Temasek says the US antitrust approval involves investments ôalready committedö by the Singapore investment firm, referring to a $3.4 billion commitment it made in July. The approval is not for any fresh capital infusion that has not been announced previously, she explains.
The spokeswoman says, however, that there are other regulatory approvals needed to finalise TemasekÆs additional $3.4 billion investment in Merrill Lynch....
¬ Haymarket Media Limited. All rights reserved.